The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2586 ENHANCED NRF2 ACTIVATION ATTENUATES<br />
FASTING-INDUCED FATTY LIVER.<br />
J. Xu 1 , J. Moscovitz 1 , M. Yamamoto 2 and A. L. Slitt 1 . 1 Biomedical and<br />
Pharmaceutical Sciences, University <strong>of</strong> Rhode Island, Kingston, RI and 2 Medical<br />
Biochemistry, Tohoku University Graduate School <strong>of</strong> Medicine, Sendai, Japan.<br />
Non-Alcoholic fatty liver disease (NAFLD) affects 20% <strong>of</strong> the U.S. population.<br />
Approximately 15 to 20% <strong>of</strong> patients with fatty liver develop a severe form <strong>of</strong> hepatic<br />
disease known as nonalcoholic steatohepatitis (NASH). <strong>The</strong> high prevalence<br />
<strong>of</strong> fatty liver and NASH warrants research into the signaling mechanisms responsible<br />
for hepatic lipid accumulation. Nuclear factor-erythroid 2-related factor 2<br />
(Nrf2, Nfe2l2), a bZIP family transcription factor, is protective against xenobioticrelated<br />
toxicity and chemical-induced carcinogenesis. However little information<br />
about Nrf2 function on lipid metabolism is available. Male C57BL/6 and Keap1-<br />
KD mice were fed ad libitum or withheld food (fasted) for 24 hours to determine<br />
whether enhanced Nrf2 activation in liver could prevent fasting-induced steatosis.<br />
In C57BL/6 mice, fasting increased hepatic triglyceride content 240%, and serum<br />
triglyceride concentrations 21% compared to fed mice. In contrast, Keap1-KD<br />
mice were resistant to fasting, with hepatic triglyceride increased 1.3 fold, and<br />
serum triglyceride levels decreased about 6% compared to fed Keap-KD mice.<br />
Fasting increased serum free fatty acid levels 110% in C57BL/6, but only 61%<br />
Keap1-KD mice. Keap1-KD mice exhibit decreased basal expression <strong>of</strong> FAS,<br />
ACC-1 and SCD-1 in liver, genes important for regulating lipid synthesis, compared<br />
to C57BL/6 mice. Fasting decreased FAS, ACC-1 and SCD-1 mRNA expression<br />
in liver to a much greater degree in Keap1-KD compared to C57BL/6<br />
mice, 54%, 31% and 81% respectively. <strong>The</strong>se data demonstrated that Keap1-KD<br />
mice are resistant to fasting-induced steatosis. Future work will focus on the mechanism<br />
by which Nrf2 activity modulates fatty acid synthesis gene expression in liver<br />
and promotes resistance to fasting. In conclusion, enhances Nrf2 activation by<br />
Keap1 knockdown prevents fasting induced steatosis, pointing to an important<br />
function on lipid metabolism (NIH 3R01ES016042-02S2).<br />
2587 PROTECTION OF RETINAL VESSELS FROM<br />
HYPEROXIC INJURY BY β-NAPHTHOFLAVONE (BNF)<br />
IN NEWBORN RATS.<br />
X. Couroucli, Y. W. Liang, L. Wang, W. Jiang and B. Moorthy. Pediatrics,<br />
Baylor College <strong>of</strong> Medicine, Houston, TX.<br />
Supplemental oxygen administration, which is routinely encountered in the treatment<br />
<strong>of</strong> premature infants suffering from respiratory distress, contributes to<br />
retinopathy <strong>of</strong> prematurity (ROP). In this study, we tested the hypothesis that exposure<br />
<strong>of</strong> newborn rats to a combination <strong>of</strong> β-napth<strong>of</strong>lavone (BNF) and hyperoxia<br />
would alleviate retinopathy and abnormal neovascularization compared to those exposed<br />
to hyperoxia alone. Newborn Fisher 344 rats were maintained in room air or<br />
exposed to hyperoxia ([gt] than 95% O2) for 7 days. Some animals were treated i.p.<br />
with BNF (20 mg/kg) or vehicle (saline), once daily for the first 4 days <strong>of</strong> hyperoxic<br />
exposures, and were sacrificed at selected time points after termination <strong>of</strong> hyperoxia.<br />
Vascular densities <strong>of</strong> flat mounted retinas were assessed. mRNA expression <strong>of</strong><br />
VEGF, its receptors (VEGFR-1/sFLT-1 and VEGFR-2), and cytochrome P4501B1<br />
(CYP1B1) was determined by real time RT-PCR. Immediately after 7 days <strong>of</strong> exposure<br />
to hyperoxia, we observed severe vaso-obliteration, compared to the hyperoxia<br />
+ BNF. Seven to thirty days after termination <strong>of</strong> hyperoxia, the animals displayed<br />
abnormal retinal vessels, whereas those given BNF+ hyperoxia showed<br />
significantly lesser extent <strong>of</strong> neovascularization. At the later time points, VEGF<br />
mRNA expression in the hyperoxia group was much higher than that <strong>of</strong> the BNF+<br />
hyperoxia group. On the other hand, the expression <strong>of</strong> VEGFR-1 and sFLT-1, but<br />
not VEGFR2, was upregulated by BNF + hyperoxia, compared to the hyperoxia<br />
only group. Interestingly, retinal CYP1B1 expression was also augmented in the<br />
BNF + hyperoxia group. Our study supported the hypothesis that BNF protects<br />
retinas from oxygen-induced retinopathy, and that upregulation <strong>of</strong> VEGFR1 as<br />
well as CYP1B1 contributes to the retinoprotective effects <strong>of</strong> BNF. Further studies<br />
are needed to elucidate the mechanisms <strong>of</strong> the protective action <strong>of</strong> BNF, which<br />
could lead to clinical trials in infants who are at risk <strong>of</strong> developing ROP.<br />
2588 HYPOXIA-ISCHEMIA TRIGGERS BAX<br />
PHOSPHORYLATION, TRANSLOCATION, AND<br />
RESULTANT CELL DEATH PHENOTYPE.<br />
S. Krishnan 1 , M. Gill 2 and R. Perez-Polo 1 . 1 Biochemistry and Molecular Biology,<br />
University <strong>of</strong> Texas Medical Branch, Galveston, TX and 2 Northwestern University,<br />
Chicago, IL. Sponsor: J. Ward.<br />
Hypoxia-ischemia (HI) in the neonatal brain can lead to DNA damage, inflammation,<br />
and cell death, all <strong>of</strong> which ultimately produce neurodevelopmental deficits.<br />
Neuronal cell death caused by HI is characterized by an array <strong>of</strong> cell death pheno-<br />
554 SOT 2011 ANNUAL MEETING<br />
types with necrotic and/or apoptotic characteristics, in which the Bcl-2 family <strong>of</strong><br />
proteins, including Bax, play a role. Here, we use well-established in vivo and in<br />
vitro models <strong>of</strong> neonatal cerebral HI, and standard molecular techniques to investigate<br />
whether HI-dependent phosphorylation <strong>of</strong> Bax at Ser163, Thr167, and/or<br />
Ser184 residues determines Bax multi-organelle localization and correlation with<br />
organelle-specific cell death signaling after HI. In rotenone-treated SH-SY5Y cells,<br />
a significant increase in p-BaxThr167 was found in mitochondrial fractions when<br />
compared to control ½ hour after treatment. In vivo, we also found an increase in<br />
p-BaxThr167 in the nucleus at 1 hour after treatment, which correlates with a decrease<br />
in mitochondrial p-BaxThr167. This may indicate that phosphorylation <strong>of</strong><br />
BaxThr167 leads to Bax translocation to the nucleus from mitochondria. We also<br />
observed an increase <strong>of</strong> p-BaxThr167 in cytosolic fractions at 1 hour, indicating<br />
that phosphorylation <strong>of</strong> BaxThr167 may be generally responsible for Bax translocation<br />
out <strong>of</strong> mitochondria. Lastly, no significant changes in p-BaxSer163 were observed<br />
up to 6 hours after HI. Interestingly, we observed a decreasing trend in cytosolic<br />
p-BaxSer163 gradually from 0 to 6 hours, as well as a significant decrease in<br />
p-BaxSer163 in the mitochondrial fraction at 6 hours after HI. <strong>The</strong>se data suggest<br />
a role for phosphorylation in the translocation <strong>of</strong> Bax after HI. Understanding the<br />
mechanisms <strong>of</strong> Bax translocation will aid in the rational design <strong>of</strong> specified therapeutic<br />
strategies which could potentially involve altering Bax subcellular redistribution<br />
to decrease the irreversible trauma resulting from a prolonged inflammatory<br />
response.<br />
2589 ESTIMATING THE GLOBAL PUBLIC HEALTH<br />
IMPLICATIONS OF ELECTRICITY AND COAL<br />
CONSUMPTION.<br />
J. M. Gohlke 1, 4 , R. Thomas 4 , A. Woodward 3 , D. Campbell-Lendrum 2 , A.<br />
Pruss-Ustun 2 , S. Hales 2 and C. J. Portier 4 . 1 Environmental Health Sciences,<br />
University <strong>of</strong> Alabama at Birmingham, Birmingham, AL, 2 Public Health and<br />
Environment, World Health Organization, Geneva, Switzerland, 3 Population Health,<br />
University <strong>of</strong> Auckland, Auckland, New Zealand and 4 Laboratory <strong>of</strong> Molecular<br />
<strong>Toxicology</strong>, NIEHS, Research Triangle Park, NC.<br />
<strong>The</strong> growing health risks associated with greenhouse gas emissions has resulted in a<br />
global call for development <strong>of</strong> new energy policies emphasizing efficiency and lowcarbon<br />
energy cycles, yet the economic and social development <strong>of</strong>ten associated<br />
with access to affordable energy are important considerations for improving health<br />
in developing nations. Here we assess the relationship between electricity consumption<br />
and health outcomes. Using time-series datasets across 41 countries with varying<br />
development trajectories between 1965 and 2005, an autoregressive model <strong>of</strong><br />
life expectancy (LE) and infant mortality (IM) was developed based on electricity<br />
consumption, coal consumption, and previous year’s LE or IM. <strong>The</strong> model predicts<br />
increased electricity consumption is associated with reduced IM for countries starting<br />
with relatively high IM (above 100 per 1000 births), whereas LE was not significantly<br />
associated with electricity consumption in any <strong>of</strong> the models. In addition,<br />
the model suggests increasing coal consumption that is not explained by electricity<br />
use is associated with increased IM and reduced LE. <strong>The</strong>se results are compared<br />
with previously published estimates <strong>of</strong> disease burdens attributable to energy-related<br />
environmental factors including indoor and outdoor air pollution, and water<br />
and sanitation. In addition, prediction <strong>of</strong> health impacts from an integrated air pollution<br />
emissions health impact model for coal-fired power plants is compared to the<br />
time-series model results. Consistency across analyses <strong>of</strong> historical time-series and<br />
health impact models suggest health benefits may be related to increasing electricity<br />
consumption in those countries with very high IM, while negative health impacts<br />
<strong>of</strong> coal consumption are predicted across all countries.<br />
2590 SELENIUM FROM OCEAN FISH PREVENTS<br />
METHYLMERCURY TOXICITY.<br />
L. Raymond and N. Ralston. Energy & Environmental Research Center, University<br />
<strong>of</strong> North Dakota, Grand Forks, ND.<br />
Supplemental selenium (Se) has been known to counteract mercury (Hg) toxicity<br />
since 1967, but the mechanisms <strong>of</strong> this protective effect have only recently become<br />
clear. Methylmercury (MeHg) is a highly specific irreversible inhibitor <strong>of</strong> Se-dependent<br />
enzymes (Se-enzymes). Supplemental dietary Se replenishes Se lost to<br />
MeHg binding, thereby maintaining normal Se-enzyme activities. Rationale and<br />
scope; Our prior animal studies have shown that the normal range <strong>of</strong> dietary Se (as<br />
sodium selenite) is effective in preventing and reversing MeHg toxicity. Since ocean<br />
fish are among the richest sources <strong>of</strong> dietary Se, we hypothesized that their Se contents<br />
would protect against the adverse effects otherwise associated with MeHg exposures<br />
from seafood consumption. Experimental procedure; In this study, 120<br />
weanling male Long Evans rats were fed diets containing either low or high MeHg<br />
(0.5 or 50 nmol MeHg/g). <strong>The</strong>se diets were augmented with either sodium selenite<br />
(~0.1, 1.0, or 10 nmol Se/g) or Se from delipidated protein isolates from bigeye